AIB1 is required for the acquisition of epithelial growth factor receptor-mediated tamoxifen resistance in breast cancer cells.
about
Prognostic relevance of AIB1 (NCoA3) amplification and overexpression in breast cancer.Prior Adjuvant Tamoxifen Treatment in Breast Cancer Is Linked to Increased AIB1 and HER2 Expression in Metachronous Contralateral Breast CancerProteomic analysis of pathways involved in estrogen-induced growth and apoptosis of breast cancer cells.ATBF1 inhibits estrogen receptor (ER) function by selectively competing with AIB1 for binding to the ER in ER-positive breast cancer cells.Steroid receptor coactivators, HER-2 and HER-3 expression is stimulated by tamoxifen treatment in DMBA-induced breast cancer.Steroid receptor coactivators 1, 2, and 3: critical regulators of nuclear receptor activity and steroid receptor modulator (SRM)-based cancer therapyOestrogen receptor-co-factor-chromatin specificity in the transcriptional regulation of breast cancer.Steroid Receptor Coactivator-3 (SRC-3/AIB1) as a Novel Therapeutic Target in Triple Negative Breast Cancer and Its Inhibition with a Phospho-Bufalin Prodrug.Annexin-A1 and caldesmon are associated with resistance to tamoxifen in estrogen receptor positive recurrent breast cancer.Endocrine resistance in breast cancer: from cellular signaling pathways to epigenetic mechanisms.HER2 and ESR1 mRNA expression levels and response to neoadjuvant trastuzumab plus chemotherapy in patients with primary breast cancerNuclear receptor coregulators as a new paradigm for therapeutic targeting.Cancer Stem Cell Phenotypes in ER+ Breast Cancer Models are Promoted by PELP1/AIB1 Complexes.
P2860
Q27852024-35CD5BC2-B5A3-464C-9966-3FE4284E392AQ28550645-E4D9C4AF-9CF1-410A-A081-3D54130017B4Q33954542-21ECC0E5-8D9D-404F-ABDB-FBA489CEFBB2Q34236787-6B3C1C7E-360F-416A-BF4E-52336E8EADD2Q34306286-6B13CBEB-2547-4EBE-8275-2319538F5C1EQ35456938-7791A1E6-8508-4121-A207-B425C8836159Q35626357-B34E5B65-1291-4F05-A0DF-A2580F2B06E2Q35796826-F454D57F-9A35-4847-910C-7A17BF3FDFF7Q36772047-66957AF1-413A-4C7C-8239-4F44BE20AE0DQ36846329-AEA69D9E-6B13-4E17-8AA1-90DAFAD5321BQ36903047-A22BA2B6-9E36-45F8-9D99-3B9D9E37FC87Q37217158-F9E45838-71D6-407B-B694-F1180EBA864AQ49954115-A4A82BAF-19AC-4CF9-834B-D1FE8A3037FC
P2860
AIB1 is required for the acquisition of epithelial growth factor receptor-mediated tamoxifen resistance in breast cancer cells.
description
2009 nî lūn-bûn
@nan
2009年の論文
@ja
2009年論文
@yue
2009年論文
@zh-hant
2009年論文
@zh-hk
2009年論文
@zh-mo
2009年論文
@zh-tw
2009年论文
@wuu
2009年论文
@zh
2009年论文
@zh-cn
name
AIB1 is required for the acqui ...... stance in breast cancer cells.
@en
AIB1 is required for the acqui ...... stance in breast cancer cells.
@nl
type
label
AIB1 is required for the acqui ...... stance in breast cancer cells.
@en
AIB1 is required for the acqui ...... stance in breast cancer cells.
@nl
prefLabel
AIB1 is required for the acqui ...... stance in breast cancer cells.
@en
AIB1 is required for the acqui ...... stance in breast cancer cells.
@nl
P2093
P1476
AIB1 is required for the acqui ...... stance in breast cancer cells.
@en
P2093
Changjie Lou
Qingyuan Zhang
Wenhui Zhao
Xinmei Kang
P304
P356
10.1016/J.BBRC.2009.01.155
P577
2009-01-29T00:00:00Z